SARS1

Chr 1AR

seryl-tRNA synthetase 1

Also known as: NEDMAS, SARS, SERRS, SERS

This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown. [provided by RefSeq, Jul 2010]

OMIMResearchGenerating clinical summary…
DNmechanismARLOEUF 0.211 OMIM phenotype
Clinical SummarySARS1
🧬
Gene-Disease Validity (ClinGen)
neurodevelopmental disorder with microcephaly, ataxia, and seizures · ARLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
3 unique Pathogenic / Likely Pathogenic· 54 VUS of 86 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.21LOEUF
pLI 0.999
Z-score 4.70
OE 0.07 (0.030.21)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.66Z-score
OE missense 0.57 (0.500.65)
170 obs / 299.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.07 (0.030.21)
00.351.4
Missense OE?0.57 (0.500.65)
00.61.4
Synonymous OE?0.82
01.21.6
LoF obs/exp: 2 / 29.6Missense obs/exp: 170 / 299.4Syn Z: 1.48
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedSARS1-related neurodevelopmental disorderDNAD
moderateSARS1-related neurodevelopmental disorder with microcephaly, ataxia, and seizuresOTHERAR

This gene — mechanism propensity

DN
0.4983th %ile
GOF
0.4480th %ile
LOF
0.4726th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.21
DN1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNComplementation assays in S. cerevisiae and serylation assays in both yeast strains and patient fibroblasts proved a loss-of-function, dominant negative effect.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 36041817

ClinVar Variant Classifications

86 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic2
VUS54
Likely Benign9
Benign5
1
Pathogenic
2
Likely Pathogenic
54
VUS
9
Likely Benign
5
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
1
1
0
0
2
VUS
1
50
2
1
54
Likely Benign
0
2
1
6
9
Benign
0
0
3
2
5
Total2546971

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 33) ClinVar copy-number / structural variants overlap SARS1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SARS1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →